Press Inquiries

The story of how drug discovery
learns to see.

Harvard-trained neuroscientist and inventor David Roberson, PhD, MBA, settled a century-old debate about pain and itch. Now, as founder and CEO of Virtual Labs, he’s building the AI to make animal research far more predictive of what happens in people—with better data that reduces the number of animals needed. He is available for interviews, podcasts, keynotes and panels.

The Story

Why this matters now.

The end of the stopwatch

Nine in ten drugs that pass animal studies fail in human trials, and the behavioral data behind them is still scored by hand. Machine vision is changing that, frame by frame, at 8,075 data points every second.

Fewer animals, better data

Regulators are moving toward animal reduction. Hand-scored data is noisy, so studies add animals just to see a real effect. Better data reduces the number of animals needed.

The inventor-founder

From a homemade “time machine” that heard itch to a patented behavior device and AI-native cameras, David builds the instruments behind his own discoveries.

Fast Facts

A track record
of breakthroughs.

2013
first-author discovery in
Nature Neuroscience
1 of 8
Harvard Horizons Scholars,
from 4,000+ PhD students
Phase 2b
clinical trials for drug
assets he co-invented
$70M+
raised by the CNS drug
companies he co-founded
2025
Tech Titans Technology
Inventor Award

Topics

What David speaks about.

The end of hand-scored behaviorAI and machine vision in drug discoveryWhy nine in ten drugs fail in the clinicThe connection between chronic pain and traumaWhy we use mice to study humansHow we stop using experimental animalsPain and itch neuroscienceInventing your own instrumentsBuilding deep-tech biotech companiesHealing PTSDOvercoming adversity

Upcoming

See it live.

NOV 14–18, 2026 · WASHINGTON, D.C.
Neuroscience 2026 (SfN), Booth 429

Meet David and see the PolarEye™ smart camera capture behavior live at the Walter E. Washington Convention Center.

Conference details →

New talks will be listed here as they are scheduled.

Contact

Tell the story with us.

Email us with your outlet, topic and deadline, and we’ll get back to you quickly. Photos and a founder bio are available on request.